Zhejiang Benli Technology Co., Ltd. (SHE:301065)

Market Cap	2.56B +29.5%
Revenue (ttm)	651.33M -8.6%
Net Income	69.95M +12.5%
EPS	0.68 +15.4%
Shares Out	103.17M
PE Ratio	36.53
Forward PE	n/a
Dividend	0.20 (0.81%)
Ex-Dividend Date	Jun 13, 2025

Volume	1,972,680
Average Volume	1,746,929
Open	24.60
Previous Close	24.72
Day's Range	24.47 - 25.17
52-Week Range	18.60 - 26.38
Beta	0.24
RSI	61.53
Earnings Date	Apr 25, 2026

About Zhejiang Benli Technology

Zhejiang Benli Technology Co., Ltd. engages in the research, development, production, and sales of pharmaceutical, pesticide, and new material intermediates in China and internationally. Its products include 2,4-Dichloro-5-fluorobenzoyl chloride, 2-(2,4-Dichloro-5-fluorobenzoyl)-3-cyclopropylamine ethyl acrylate, 1-Ethyl-7-(1-piperazinyl) -6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acid hydrochloride, 2,4-Dichlorofluorobenzene, and Methyl 3-methoxyacrylate; and Ethyl N,N-dimethylaminoacrylate, 2,6-Dichlorofluorobenzene, and 3-(2-Ethylene...

• Industry: Chemicals
• Sector: Materials
• Founded: 2011
• Employees: 589
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301065

Financial Performance

In 2024, Zhejiang Benli Technology's revenue was 708.83 million, an increase of 1.57% compared to the previous year's 697.89 million. Earnings were 64.57 million, an increase of 8.31%.